VJHemOnc is committed to improving our service to you

EHA 2020 | NGS: changes in CLL management

VJHemOnc is committed to improving our service to you

Richard Rosenquist Brandell

Richard Rosenquist Brandell, MD, of Karolinska Institute, Solna, Stockholm, discusses how the management of chronic lymphocytic leukemia (CLL) has changed since the advent of next-generation techniques as well as gene panel assays currently used for CLL prognosis and resistance assesment. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter